Haemophilus ducreyi is susceptible to protegrin

被引:18
作者
Fortney, K
Totten, PA
Lehrer, RI
Spinola, SM
机构
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[4] Univ Washington, Dept Med, Seattle, WA 98104 USA
[5] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
D O I
10.1128/AAC.42.10.2690
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Protegrins, potent antimicrobial peptides found in pol cine leukocytes, have activity against the sexually transmitted pathogens Neisseria gonorrhoeae, Chlamydia trachomatis, and human immunodeficiency virus type I. We tested synthetic protegrin 1 (PG-I) for activity against nine isolates of Haemophilus ducreyi, the etiologic agent of chancroid, The test organisms included CIP 542 (the type strain). 35000HP (a human-passaged variant of 35000), 35000HP-RSM2 tan isogenic D-glycero-D-manno-heptosyltransferase mutant of 35000HP), and six clinical isolates. The isolates were epidemiologically unrelated, represented three HindIII ribotypes, and had varying antimicrobial resistance patterns. In bactericidal assays, live isolates were rapidly; killed bq synthetic PG-1, In radial diffusion assays, all nine isolates were exquisitely sensitive to PG-I, These data highlight the potential of protegrins for development as topical agents to prevent many sexually transmitted diseases, including chancroid.
引用
收藏
页码:2690 / 2693
页数:4
相关论文
共 25 条
  • [1] SEXUALLY-TRANSMITTED DISEASES AND HUMAN-IMMUNODEFICIENCY-VIRUS CONTROL IN MALAWI - A FIELD-STUDY OF GENITAL ULCER DISEASE
    BEHETS, FMT
    LIOMBA, G
    LULE, G
    DALLABETTA, G
    HOFFMAN, IF
    HAMILTON, HA
    MOENG, S
    COHEN, MS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 451 - 455
  • [2] ANTIMICROBIAL SUSCEPTIBILITY OF HAEMOPHILUS-DUCREYI
    DANGOR, Y
    BALLARD, RC
    MILLER, SD
    KOORNHOF, HJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) : 1303 - 1307
  • [3] Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis
    Gibson, BW
    Campagnari, AA
    Melaugh, W
    Phillips, NJ
    Apicella, MA
    Grass, S
    Wang, J
    Palmer, KL
    Munson, RS
    [J]. JOURNAL OF BACTERIOLOGY, 1997, 179 (16) : 5062 - 5071
  • [4] Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations
    Harwig, SSL
    Waring, A
    Yang, HJ
    Cho, Y
    Tan, L
    Lehrer, RI
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (02): : 352 - 357
  • [5] CELL-WALL ULTRASTRUCTURE OF STRAINS OF HAEMOPHILUS-DUCREYI AND HAEMOPHILUS-PISCIUM
    KILIAN, M
    THEILADE, J
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1975, 25 (04): : 351 - 356
  • [6] IN-VITRO SUSCEPTIBILITIES OF ISOLATES OF HAEMOPHILUS-DUCREYI FROM THAILAND AND THE UNITED-STATES TO CURRENTLY RECOMMENDED AND NEWER AGENTS FOR TREATMENT OF CHANCROID
    KNAPP, JS
    BACK, AF
    BABST, AF
    TAYLOR, D
    RICE, RJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) : 1552 - 1555
  • [7] PROTEGRINS - LEUKOCYTE ANTIMICROBIAL PEPTIDES THAT COMBINE FEATURES OF CORTICOSTATIC DEFENSINS AND TACHYPLESINS
    KOKRYAKOV, VN
    HARWIG, SSL
    PANYUTICH, EA
    SHEVCHENKO, AA
    ALESHINA, GM
    SHAMOVA, OV
    KORNEVA, HA
    LEHRER, RI
    [J]. FEBS LETTERS, 1993, 327 (02) : 231 - 236
  • [8] ULTRASENSITIVE ASSAYS FOR ENDOGENOUS ANTIMICROBIAL POLYPEPTIDES
    LEHRER, RI
    ROSENMAN, M
    HARWIG, SSSL
    JACKSON, R
    EISENHAUER, P
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 137 (02) : 167 - 173
  • [9] The lipooligosaccharides of Haemophilus ducreyi are highly sialylated
    Melaugh, W
    Campagnari, AA
    Gibson, BW
    [J]. JOURNAL OF BACTERIOLOGY, 1996, 178 (02) : 564 - 570
  • [10] CHANCROID AND HEMOPHILUS-DUCREYI
    MORSE, SA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (02) : 137 - 157